Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
POU3F3 adjacent non-coding transcript 1 (PANTR1) is a long non-coding RNA gene (lncRNA), highly conserved between human and mouse, which modulates the site-specific chromatin binding of transcription factors such as FOXG1 and NEUROD1 during neuronal development. PANTR1 is transcriptionally regulated by FOXG1 and, in turn, governs FOXG1’s localization at select genome regions, thereby influencing the epigenetic landscape and neuronal differentiation. Although synonyms suggest possible relevance in cancer, its best-documented and canonical role is as a neural regulator, contributing mechanistically to FOXG1-syndrome and neuronal outgrowth. There are no drugs or small molecules known to target PANTR1 directly, and it is not considered a classical "therapeutic target" but rather a biological modulator of cell phenotype.
not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on POU3F3 adjacent non-coding transcript 1 (PANTR1).